URNG:LSE:LSE-Global X Uranium UCITS ETF USD Acc GBP (GBP)

ETF | Others |

Last Closing

USD 11.773

Change

-0.26 (-2.15)%

Market Cap

USD 0.15B

Volume

0.05M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-4.75 (-2.49%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-0.84 (-0.70%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.08 (-0.45%)

USD 572.76B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.05 (-0.38%)

USD 572.76B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.25 (-0.35%)

USD 266.08B
0QZO:LSE 0QZO

-1.05 (-1.09%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-4.82 (-2.77%)

USD 202.26B
PRJU:LSE Amundi Index Solutions - Amund..

-0.12 (-0.38%)

USD 200.79B
0R24:LSE Intel Corp.

-0.35 (-1.47%)

USD 196.14B

ETFs Containing URNG:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.57% 21% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.57% 20% F 32% F
Trailing 12 Months  
Capital Gain 2.31% 19% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.31% 18% F 31% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 10.03% N/A N/A 69% C-
Dividend Return 10.03% N/A N/A 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 31.74% N/A N/A 29% F
Risk Adjusted Return 31.60% N/A N/A 60% D-
Market Capitalization 0.15B 56% F 31% F

Annual Financials (GBP)

Quarterly Financials (GBP)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike